| 1 |
30385739 | Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism. | 2018 Nov 1 |
2 |
| 2 |
27494880 | Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide. | 2016 Sep 20 |
1 |
| 3 |
26506422 | Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL. | 2015 Dec 8 |
1 |
| 4 |
24571452 | ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21((CIP1/WAF1)) in human cancer cells. | 2014 Jul |
2 |
| 5 |
24121507 | p62/sequestosome-1 up-regulation promotes ABT-263-induced caspase-8 aggregation/activation on the autophagosome. | 2013 Nov 22 |
1 |
| 6 |
22037880 | ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein. | 2012 Mar |
2 |
| 7 |
23190604 | ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells. | 2012 Nov 29 |
3 |
| 8 |
19097992 | Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids. | 2009 Jul |
1 |
| 9 |
18413764 | BH3 mimetic ABT-737 potentiates TRAIL-mediated apoptotic signaling by unsequestering Bim and Bak in human pancreatic cancer cells. | 2008 Apr 15 |
3 |
| 10 |
18599488 | ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis. | 2008 Sep 5 |
2 |